BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38931449)

  • 1. Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease.
    Zhao Y; Lin M; Zhai F; Chen J; Jin X
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
    Liang Y; Zhong G; Ren M; Sun T; Li Y; Ye M; Ma C; Guo Y; Liu C
    Neuromolecular Med; 2023 Dec; 25(4):471-488. PubMed ID: 37698835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
    Momtaz S; Memariani Z; El-Senduny FF; Sanadgol N; Golab F; Katebi M; Abdolghaffari AH; Farzaei MH; Abdollahi M
    Front Physiol; 2020; 11():361. PubMed ID: 32411012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease.
    Suresh K; Mattern M; Goldberg MS; Butt TR
    Neuromolecular Med; 2023 Sep; 25(3):313-329. PubMed ID: 36739586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.
    Potjewyd FM; Axtman AD
    Front Cell Neurosci; 2021; 15():768655. PubMed ID: 34867205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinson's Disease.
    Tiwari S; Singh A; Gupta P; Singh S
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.
    Lu L; Jifu C; Xia J; Wang J
    Biomed Pharmacother; 2024 Jun; 175():116753. PubMed ID: 38761423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
    Fishman-Jacob T; Youdim MBH
    J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.
    Conway JA; Kinsman G; Kramer ER
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
    Park GH; Park JH; Chung KC
    BMB Rep; 2021 Dec; 54(12):592-600. PubMed ID: 34674795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.
    Do HA; Baek KH
    Ageing Res Rev; 2021 Aug; 69():101367. PubMed ID: 34023421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin E3 ligase Parkin regulates neuronal Ca
    Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
    J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology.
    Sahu M; Rani N; Kumar P
    Mol Biotechnol; 2024 May; 66(5):1095-1115. PubMed ID: 38172369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal Upshot of Nitric Oxide, Endoplasmic Reticulum Stress, and Ubiquitin Proteasome System in Parkinson's Disease Pathology.
    Tiwari S; Singh S
    Neuroscientist; 2021 Aug; 27(4):340-354. PubMed ID: 32713286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the ubiquitin proteasome system in Parkinson's disease.
    Lim KL; Tan JM
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S13. PubMed ID: 18047737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.